Desipramine selectively potentiates norepinephrine-elicited ERK1/2 activation through the α 2A adrenergic receptor

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 161-165

  Cottingham, Christopher ^a   Jones, Adrian ^a   Wang, Qin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

2 Adrenergic receptor; Akt; Antidepressant; ERK1 2; Norepinephrine

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; DESIPRAMINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NORADRENALIN; RETINA S ANTIGEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVATION; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARRESTIN; CELLS, CULTURED; DESIPRAMINE; DRUG SYNERGISM; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NOREPINEPHRINE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION;

EID: 84862788699     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.135     Document Type: Article

References (25)

1. Baldessarini R.J. Drug therapy of depression and anxiety disorders. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2006, 429-460. McGraw-Hill, Inc., New York. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
2. Knaus A.E., Muthig V., Schickinger S., Moura E., Beetz N., Gilsbach R., Hein L. Alpha2-adrenoceptor subtypes-unexpected functions for receptors and ligands derived from gene-targeted mouse models. Neurochem. Int. 2007, 51(5):277-281.
3. Mateo Y., Pineda J., Meana J.J. Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J. Neurochem. 1998, 71(2):790-798.
4. Linner L., Arborelius L., Nomikos G.G., Bertilsson L., Svensson T.H. Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade. Biol. Psychiatry 1999, 46(6):766-774.
5. Cottingham C., Chen Y., Jiao K., Wang Q. The antidepressant desipramine is an arrestin-biased ligand at the alpha2A adrenergic receptor driving receptor downregulation in vitro and in vivo. J. Biol. Chem. 2011, 286:36063-36075.
6. Limbird L.E. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. The FASEB J: Official Publication Fed. Am. Societies Exp. Biol. 1988, 2(11):2686-2695.
7. Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Annu. Rev. Neurosci. 1992, 15:87-114.
8. Richman J.G., Regan J.W. Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am. J. Physiol. 1998, 274(3 Pt 1):C654-662.
9. Wang Q., Zhao J., Brady A.E., Feng J., Allen P.B., Lefkowitz R.J., Greengard P., Limbird L.E. Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. Science 2004, 304(5679):1940-1944.
10. Wang Q., Lu R., Zhao J., Limbird L.E. Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent. ERK activation. J. Biol. Chem. 2006, 281(36):25948-25955.
11. Duman C.H., Schlesinger L., Kodama M., Russell D.S., Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 2007, 61(5):661-670.
12. Li X., Jope R.S. Is glycogen synthase kinase-3 a central modulator in mood regulation?. Neuropsychopharmacology 2010, 35(11):2143-2154.
13. Kohout T.A., Lin F.S., Perry S.J., Conner D.A., Lefkowitz R.J. Beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(4):1601-1606.
14. Alblas J., van Corven E.J., Hordijk P.L., Milligan G., Moolenaar W.H. Gi-mediated activation of the p21ras-mitogen-activated protein kinase pathway by alpha 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 1993, 268(30):22235-22238.
15. Koch W.J., Hawes B.E., Allen L.F., Lefkowitz R.J. Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras. Proc. Natl. Acad. Sci. U.S.A. 1994, 91(26):12706-12710.
16. Mateo Y., Fernandez-Pastor B., Meana J.J. Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study. Br. J. Pharmacol. 2001, 133(8):1362-1370.
17. Murga C., Laguinge L., Wetzker R., Cuadrado A., Gutkind J.S. Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma. J. Biol. Chem. 1998, 273(30):19080-19085.
18. Cottingham C., Li X., Wang Q. Noradrenergic antidepressant responses to desipramine in vivo are reciprocally regulated by arrestin3 and spinophilin. Neuropharmacology 2012, 10.1016/j.neuropharm.2012.02.011.
19. Violin J.D., Lefkowitz R.J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 2007, 28(8):416-422.
20. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 2010, 9(5):373-386.
21. Redka D.S., Pisterzi L.F., Wells J.W. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor. Mol. Pharmacol. 2008, 74(3):834-843.
22. Limbird L.E. Cell Surface Receptors: A Short Course on Theory and Methods 2005, Springer Science+Business Media, Inc., New York.
23. Small K.M., Schwarb M.R., Glinka C., Theiss C.T., Brown K.M., Seman C.A., Liggett S.B. Alpha2A- and alpha2C-adrenergic receptors form homo- and heterodimers: the heterodimeric state impairs agonist-promoted GRK phosphorylation and beta-arrestin recruitment. Biochemistry 2006, 45(15):4760-4767.
24. Smith N.J., Milligan G. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol. Rev. 2010, 62(4):701-725.
25. C. Cottingham, H. Chen, Y. Chen, Y. Peng, Q. Wang, Genetic variations of alpha2-adrenergic receptors illuminate the diversity of receptor functions. In: Wang, Q., (Ed.), Current Topics in Membranes, Vol. 67, Elsevier Inc., Amsterdam, 2011.